Get access

Allergic bronchopulmonary aspergillosis and omalizumab

Authors


  • Omalizumab in Allergic bronchopulmonary aspergillosis is associated with fewer episodes of exacerbation and reduction of steroids dose.

Service de Pneumologie et d’Immuno-Allergologie
Hôpital Calmette University Lille 2
INSERM U1019 IFR 142
1, bd Leclercq
CHRU, 59037, Lille
France
Tel.: +33320444318
Fax: +33320444709
E-mail: i-tillie@chru-lille.fr

No abstract is available for this article.

Ancillary